Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens-Reference-Cited by-同舟云学术

Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens

Published:2020-12-08 Issue:2 Volume:44 Page:68-73
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Marks Eric I.,Matera Robert,Olszewski Adam J.,Yakirevich Evgeny,El-Deiry Wafik S.,Safran Howard,Carneiro Benedito A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference26 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale;Colucci;J Clin Oncol,2005

3. Mechanism of action of camptothecin;Liu;Ann N Y Acad Sci,2000

4. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I;Covey;Cancer Res,1989

5. Oxaliplatin: a review in the era of molecularly targeted therapy;Alcindor;Curr Oncol,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC;Frontiers in Surgery;2024-06-14

2. Molecular insights from comprehensive genomic profiling data in advanced metastatic colorectal cancer in South Asian population: A retrospective observational study;Cancer Research, Statistics, and Treatment;2024-04

3. Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy;Cancer Cell International;2023-04-17

4. Atm Or Chek2 Alterations as Potential Biomarkers of Improved Outcomes with Irinotecan: Real-World Analysis of Advanced Pancreatic Ductal Adenocarcinoma;2023

5. Colorectal Cancer Immunotherapy: State of the Art and Future Directions;Gastro Hep Advances;2023